89
Views
4
CrossRef citations to date
0
Altmetric
Original papers

Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update

, MD, &
Pages 633-641 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Lu Zhou, Huiping Shi, Wenyu Shi, Li Yang, Yaping Zhang, Mengqi Xu, Xiufang Chen, Yanv Zhu, Hui Mu, Xiaochun Wan, Zhonghua Yang, Ying Zeng & Hong Liu. (2019) Durable Molecular Remission in a Lymphoid BP-CML Patient Harboring T315I Mutation Treated with Anti-CD19 CAR-T Therapy. OncoTargets and Therapy 12, pages 10989-10995.
Read now
Ester Maria Orlandi, Chiara Elena & Elisa Bono. (2017) Risk of hepatitis B reactivation under treatment with tyrosine-kinase inhibitors for chronic myeloid leukemia. Leukemia & Lymphoma 58:7, pages 1764-1766.
Read now
Anna Kreutzman, Mette Ilander, Kimmo Porkka, Jukka Vakkila & Satu Mustjoki. (2014) Dasatinib promotes Th1-type responses in granzyme B expressing T-cells. OncoImmunology 3:5.
Read now
Fu-Hua Zhang, Yi-Wen Ling, Xiao Zhai, Yu Zhang, Fen Huang, Zhi-Ping Fan, Hong-Sheng Zhou, Qian-Li Jiang, Jing Sun & Qi-Fa Liu. (2013) The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology 18:3, pages 151-157.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.